Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | cytochrome P450, family 2, subfamily C, polypeptide 9 | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Loa Loa (eye worm) | cytochrome P450 family protein | Get druggable targets OG5_126582 | All targets in OG5_126582 |
Brugia malayi | Cytochrome P450 family protein | Get druggable targets OG5_126582 | All targets in OG5_126582 |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Mycobacterium tuberculosis | Probable cytochrome P450 136 Cyp136 | cytochrome P450, family 2, subfamily C, polypeptide 9 | 490 aa | 441 aa | 21.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | Solute carrier family 22 5 | 0.202248 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0108589 | 0.0431787 | 0.484402 |
Loa Loa (eye worm) | hypothetical protein | 0.0108589 | 0.0431787 | 0.484402 |
Trypanosoma cruzi | carbonic anhydrase-like protein, putative | 0.020052 | 0.0891382 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0108589 | 0.0431787 | 0.484402 |
Echinococcus granulosus | carbonic anhydrase II | 0.020052 | 0.0891382 | 0.0480335 |
Trypanosoma brucei | carbonic anhydrase-like protein | 0.020052 | 0.0891382 | 0.5 |
Trypanosoma cruzi | carbonic anhydrase-like protein, putative | 0.020052 | 0.0891382 | 0.5 |
Brugia malayi | Eukaryotic-type carbonic anhydrase family protein | 0.0108589 | 0.0431787 | 0.484402 |
Brugia malayi | Eukaryotic-type carbonic anhydrase family protein | 0.020052 | 0.0891382 | 1 |
Echinococcus multilocularis | carbonic anhydrase II | 0.020052 | 0.0891382 | 1 |
Brugia malayi | Eukaryotic-type carbonic anhydrase family protein | 0.0108589 | 0.0431787 | 0.484402 |
Brugia malayi | Putative carbonic anhydrase 5 precursor | 0.020052 | 0.0891382 | 1 |
Loa Loa (eye worm) | eukaryotic-type carbonic anhydrase | 0.0108589 | 0.0431787 | 0.484402 |
Schistosoma mansoni | carbonic anhydrase II (carbonate dehydratase II) | 0.020052 | 0.0891382 | 1 |
Mycobacterium tuberculosis | Probable epoxide hydrolase EphA (epoxide hydratase) (arene-oxide hydratase) | 0.0152087 | 0.0649247 | 0.5 |
Brugia malayi | Carbonic anhydrase like protein 2 precursor | 0.0108589 | 0.0431787 | 0.484402 |
Loa Loa (eye worm) | eukaryotic-type carbonic anhydrase | 0.020052 | 0.0891382 | 1 |
Plasmodium falciparum | carbonic anhydrase | 0.0108589 | 0.0431787 | 0.5 |
Loa Loa (eye worm) | carbonic anhydrase 3 | 0.020052 | 0.0891382 | 1 |
Brugia malayi | Carbonic anhydrase like protein 2 precursor | 0.0108589 | 0.0431787 | 0.484402 |
Toxoplasma gondii | hypothetical protein | 0.0108589 | 0.0431787 | 0.5 |
Leishmania major | carbonic anhydrase-like protein | 0.020052 | 0.0891382 | 0.5 |
Mycobacterium ulcerans | epoxide hydrolase EphA | 0.0152087 | 0.0649247 | 0.5 |
Brugia malayi | Eukaryotic-type carbonic anhydrase family protein | 0.0108589 | 0.0431787 | 0.484402 |
Schistosoma mansoni | carbonic anhydrase II (carbonate dehydratase II) | 0.020052 | 0.0891382 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
CL (ADMET) | Clearance in mouse at 5 mg/kg, iv | ChEMBL. | 20568778 | |
IC50 (ADMET) | Inhibition of CYP2D6 in human liver microsome by LC-MS/MS analysis | ChEMBL. | 20568778 | |
IC50 (ADMET) | Inhibition of CYP3A4 in human liver microsome by LC-MS/MS analysis | ChEMBL. | 20568778 | |
IC50 (functional) | = 116 nM | Antimalarial activity against drug-sensitive Plasmodium falciparum NF54 infected in human erythrocytes after 48 hrs by [3H]hypoxanthine assay | ChEMBL. | 20568778 |
IC50 (ADMET) | > 10 uM | Inhibition of CYP2C9 in human liver microsome by LC-MS/MS analysis | ChEMBL. | 20568778 |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 | 20568778 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.